Legato Capital Management LLC Purchases New Shares in Astrana Health, Inc. $ASTH

Legato Capital Management LLC purchased a new stake in Astrana Health, Inc. (NASDAQ:ASTH) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 27,739 shares of the company’s stock, valued at approximately $688,000.

A number of other hedge funds and other institutional investors have also modified their holdings of ASTH. Signaturefd LLC boosted its position in shares of Astrana Health by 57.9% in the 4th quarter. Signaturefd LLC now owns 1,058 shares of the company’s stock valued at $26,000 after purchasing an additional 388 shares during the period. GAMMA Investing LLC boosted its position in shares of Astrana Health by 144.7% in the 4th quarter. GAMMA Investing LLC now owns 1,473 shares of the company’s stock valued at $37,000 after purchasing an additional 871 shares during the period. Strs Ohio acquired a new position in shares of Astrana Health in the 4th quarter valued at $40,000. Tower Research Capital LLC TRC boosted its position in shares of Astrana Health by 323.3% in the 2nd quarter. Tower Research Capital LLC TRC now owns 4,605 shares of the company’s stock valued at $115,000 after purchasing an additional 3,517 shares during the period. Finally, State of Wyoming acquired a new position in shares of Astrana Health in the 2nd quarter valued at $132,000. Institutional investors and hedge funds own 52.77% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on the company. BTIG Research increased their price target on Astrana Health from $40.00 to $50.00 and gave the company a “buy” rating in a research report on Friday, May 8th. TD Cowen raised their price objective on Astrana Health from $35.00 to $45.00 and gave the stock a “buy” rating in a research report on Tuesday, May 12th. Weiss Ratings upgraded Astrana Health from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, April 29th. Zacks Research upgraded Astrana Health from a “strong sell” rating to a “hold” rating in a research report on Wednesday, March 11th. Finally, Truist Financial raised their price objective on Astrana Health from $38.00 to $47.00 and gave the stock a “buy” rating in a research report on Thursday, May 14th. Seven research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $45.00.

Astrana Health Trading Up 1.8%

Shares of NASDAQ ASTH opened at $38.54 on Wednesday. Astrana Health, Inc. has a one year low of $18.08 and a one year high of $39.93. The firm has a market capitalization of $2.15 billion, a PE ratio of 63.18 and a beta of 0.98. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 1.20. The business has a 50-day moving average price of $31.28 and a two-hundred day moving average price of $26.19.

Astrana Health (NASDAQ:ASTH) last announced its quarterly earnings data on Thursday, May 7th. The company reported $0.74 EPS for the quarter, topping analysts’ consensus estimates of $0.29 by $0.45. Astrana Health had a return on equity of 9.22% and a net margin of 0.86%.The firm had revenue of $965.10 million during the quarter, compared to analyst estimates of $949.21 million. During the same period last year, the company posted $0.42 EPS. The business’s quarterly revenue was up 55.6% compared to the same quarter last year. As a group, analysts predict that Astrana Health, Inc. will post 1.25 earnings per share for the current fiscal year.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.